Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-016667

Chief Strategy Officer sold 10,348 shares at $9.04 ($93,546)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nayak Sanjay · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-12 Sale : show line 1 in the form 10b5-1 −10,348 $9.04 $93,546 332,412 D
Open-market sales · 10,348 sh · avg $9.04 · $93,546
Loading xslF345X05/tm266494-3_4seq1.xml…